Varenicline Tablet, Film Coated
Product Images NDC 70748-127

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 70748-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5f079949 4bdb 4c58 9608 31d9599f9a0b 01)

Chemical structure of varenicline, the active ingredient in the prescription drug VARENICLINE by Lupin Pharmaceuticals, Inc.*

FDA Label Image

Image (5f079949 4bdb 4c58 9608 31d9599f9a0b 02)

Bar chart comparing percentages across several studies labeled Study 2, Study 3, Study 4, and Study 5. Each study shows data bars for Varenicline Tablets at various dosages, Bupropion SR 150 mg BID, and Placebo groups, with percentages on the y-axis ranging from 0% to 35%. Error bars are included to indicate variability.*

FDA Label Image

Image (5f079949 4bdb 4c58 9608 31d9599f9a0b 03)

Line graph comparing the percentage of continuous abstinent subjects over time for Varenicline tablets 1.0 mg BID versus placebo. The x-axis shows nontreatment follow-up in weeks, while the y-axis represents the percentage of continuous abstinent participants, depicting a decline over the follow-up periods for both groups with Varenicline showing a higher abstinence rate than placebo.*

FDA Label Image

Image (5f079949 4bdb 4c58 9608 31d9599f9a0b 04)

A line graph comparing continuous abstinent percentages over weeks of nontreatment follow-up between Varenicline Tablets 1.0 mg BID and placebo groups. The x-axis shows nontreatment follow-up in weeks; the y-axis shows the percentage of continuous abstinent subjects, illustrating a higher abstinence rate with Varenicline over time compared to placebo.*

FDA Label Image

0.5 mg (5f079949 4bdb 4c58 9608 31d9599f9a0b 05)

Varenicline Tablets 0.5 mg film coated oral tablets packaging label by Lupin Pharmaceuticals, Inc. The label indicates each tablet contains 0.5 mg varenicline free base equivalent, with a total package size of 56 tablets. Storage instructions and manufacturing details are also visible.*

FDA Label Image

Figure 1 (5f079949 4bdb 4c58 9608 31d9599f9a0b 06)

Label for Varenicline Tablets 1 mg, film-coated oral tablets produced by Lupin Pharmaceuticals, Inc. The label indicates a package count of 56 tablets. It includes storage instructions, dosage form, and manufacturer details, with NDC 70748-128-49 visible on the label.*

FDA Label Image

Figure 2 (5f079949 4bdb 4c58 9608 31d9599f9a0b 07)

Varenicline Tablets tablet blister pack and carton from Lupin Pharmaceuticals, Inc. The label includes patient directions for use over a 4-week dosing schedule, with one green and three blue blister cards containing circular tablet cavities. The packaging highlights Varenicline tablets, film-coated, with instructions to place a pharmacy label on the carton.*

FDA Label Image

Figure 3 (5f079949 4bdb 4c58 9608 31d9599f9a0b 08)

Varenicline Tablets 1 mg film-coated oral tablets packaging label featuring a continuous pack of 56 tablets organized in blister trays. The label includes dosage instructions for a 4-week treatment course, pharmacy label placement area, barcodes, manufacturer Lupin Pharmaceuticals, Inc., and storage information. The pack is marked for prescription use only and displays the NDC 70748-126-11.*

FDA Label Image

Figure 4 (5f079949 4bdb 4c58 9608 31d9599f9a0b 09)

Varenicline Tablets Starting Month Pack label for oral film-coated tablets by Lupin Pharmaceuticals, Inc. The pack contains 0.5 mg and 1 mg strength tablets (11 tablets of 0.5 mg and 42 tablets of 1 mg) for the first 4 weeks. The label includes dosage instructions, storage conditions, and safety warnings. The NDC number 70748-125-11 is shown along with manufacturer details.*

FDA Label Image

Figure 5 (5f079949 4bdb 4c58 9608 31d9599f9a0b 10)

Varenicline Tablets 1 mg per tablet oral film-coated tablets package label for a continuing month pack containing 56 tablets (4 continuing weeks). The label includes dosage instructions, storage conditions, and warnings. Manufactured by Lupin Pharmaceuticals, Inc., the package is not child-resistant and intended for households without young children. Rx only.*

FDA Label Image

Figure 6 (5f079949 4bdb 4c58 9608 31d9599f9a0b 11)

Varenicline Tablets starting month box packaging for oral film-coated tablets. Contains 0.5 mg tablets (11 tablets for starting week) and 1 mg tablets (42 tablets for continuing weeks). Manufactured by Lupin Limited and labeled for Lupin Pharmaceuticals, Inc. Includes dosage instructions and storage conditions on the box.*

FDA Label Image

Figure 7 (5f079949 4bdb 4c58 9608 31d9599f9a0b 12)

Packaging label for Varenicline Tablets Starting Month Box by Lupin Pharmaceuticals, Inc. The box contains film-coated tablets with strengths of 0.5 mg and 1 mg. It includes 1 starting week supply (0.5 mg x 11 tablets) and 3 continuing weeks supply (1 mg x 42 tablets). Label notes this is a prescription product and not child resistant, for households without young children.*

FDA Label Image

Figure 8 (5f079949 4bdb 4c58 9608 31d9599f9a0b 13)

Varenicline Tablets 1 mg per tablet film-coated oral tablets in a continuing month box containing 56 tablets (1 mg × 56 tablets). Labeler is Lupin Pharmaceuticals, Inc. Packaging states pharmacist should dispense the Medication Guide separately. The package is not child-resistant and is intended for households without young children.*

FDA Label Image

Figure 9 (5f079949 4bdb 4c58 9608 31d9599f9a0b 14)

Packaging label for Varenicline Tablets 1 mg film-coated tablets by Lupin Pharmaceuticals, Inc. The label states this is a continuing month box containing 4 continuing weeks (1 mg × 56 tablets). It includes storage instructions, dosing guidance to take one 1 mg tablet in the morning and evening, and notes the package is not child resistant. Manufacturer is Lupin Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.